Meagan is a PhD candidate in the Jewett and Tullman-Ercek Labs at Northwestern University. Her research focuses on improving cell-free protein synthesis systems in order to rapidly develop and manufacture medical therapeutics. She completed her B.S. in chemical engineering at the University of Arkansas. Outside of the lab, Meagan enjoys cooking, reading, and hiking.
Dr. Woolston joined the NEU Chemical Engineering department as an Assistant Professor in January 2020. As an NSF Graduate Research Fellow, Dr. Woolston received his PhD in Chemical Engineering in 2017 from MIT under the guidance of Prof. Greg Stephanopoulos, where his research focused on the development of genetic tools to enable metabolic engineering in anaerobic CO2-fixing microbes, and the establishment of a methanol utilization pathway in the model organism Escherichia coli. While at MIT, he was an inaugural Fellow of the Chemical Engineering Communication Lab, where he provided peer tutoring and department-wide workshops to assist students and post-docs with aspects of scientific communication. His Post-doctoral work was conducted in the laboratory of Prof. Emily Balskus in the Chemistry & Chemical Biology department at Harvard University, where he studied microbial metabolic pathways and enzymes that contribute to the stability of health-associated Lactobacilli in the human vaginal microbiota. At Northeastern, his research program combines approaches from his previous research training in metabolic engineering, synthetic biology, biochemistry and microbiology to engineer microbes for biofuel & biochemical production, and as diagnostics and therapeutics in the Human gut microbiota. His lab team currently consists of five PhD students and five undergraduates. Since joining NEU, Dr. Woolston has taught the Biochemical Engineering senior elective (CHME 5630) and the graduate course in Kinetics & Reactor Design (CHME 7340). He was the winner of the 2020 IMES Jay Bailey Award young investigator award, as well as the 2021 Biotechnology & Bioengineering Daniel I.C. Wang award.
Degree in Biology from the Universidad Veracruzana, Mexico. Master’s degree in Bioethics from the Anahuac University, Mexico. Doctorate in Sciences from the Scientific Research Center of Yucatán A.C., Mérida, Yucatán. Mexico. Postdoctoral fellow at the Donald Danforth Plant Science Center. St.Louis Missouri, United States.
Currently:
-Titular Type A Researcher at the Center for Research and Assistance in Technology and Design of the State of Jalisco A.C. (CIATEJ), Zapopan Headquarters. Department of Industrial Biotechnology, Zapopan, Jalisco, Mexico. Distinction by the National System of Researchers (SNI I).
-General Coordinator of the “National Network of Synthetic Biology of Mexico”.
-Coordinator of the research sub-line “Synthetic Biology” within the Department of Industrial Biotechnology of the Center for Research and Assistance in Technology and Design of the State of Jalisco A.C. (CIATEJ). In the working group, state-of-the-art sequencing (Oxford Nanopore Technologies) is performed in yeast and bioinformatic analysis of omics data (genome, transcriptome, metagenome). Design of transformation systems through synthesis and Gibson assembly. We use CRISPR-Cas9, dCas9 and Cas13, in order to edit or regulate genes to check functionality in cell lines of animals, bacteria, yeast, marine organisms and plants.
Chad Haynes is the Director of Government Strategy and Technology Partnerships at LanzaTech, Inc. In this role, he works across the company’s science, engineering, and government relations teams to help coordinate and design R&D projects with mutual interest and benefit to Federal agencies and offices. Additionally, his role involves engagement with policy and regulatory stakeholders to help accelerate the deployment of sustainable technologies. Prior to joining LanzaTech, Dr. Haynes was a Lead Associate at Booz Allen Hamilton, serving as a technology and management consultant to U.S. Dept. of Energy ARPA-E and the U.S. Biomass R&D Board. He previously served as an AAAS Science and Technology Policy Fellow at the USDA ARS. He holds a PhD in Biochemistry from the University of Kentucky, and completed postdoctoral training at Caltech.
Natalie Gogotsi is a Materials Engineer at Lockheed Martin’s Advanced Development Programs (Skunk Works) as part of the Revolutionary Technology Program. She received a joint B.S./M.S. in Chemical Engineering from Drexel University with a minor in Materials Science and Engineering. She then went on to receive her Ph.D. in Materials Science and Engineering from the University of Pennsylvania where her research focused on developing quantum dots for optical applications. Since joining Lockheed Martin in early 2020 she’s become heavily involved in the Engineered Biology Portfolio, helping grow the portfolio as both a technical contributor and project lead. In addition to the Engineered Biology work, she also works on topic areas including metamaterials and other advanced materials.
Dr. Adam Woomer is a materials scientist at the Advanced Technology Center in Lockheed Martin Space, which specializes in the incorporation of advanced materials into next-generation devices and applications. In collaboration with the Army Research Laboratory, Dr. Woomer is currently applying his materials expertise to the field of synthetic biology, with a particular focus on the self-assembly and design of novel materials for protective coatings and optical technologies. Before joining Lockheed Martin in 2019, he received his Ph.D. in chemistry from the University of North Carolina at Chapel Hill in 2018 and his B.S. in chemistry from the University of Connecticut in 2013.
Dr. Jeff Stuart is the Biotechnology and Engineered Biology Tech Domain Lead for Lockheed Martin’s Corporate Global Research and Technology Innovation Team, within the Chief Technology Officer’s organization. He is a subject matter expert in nanobiotechnology and has led a diverse portfolio of programs covering a wide variety of topics, including synthetic biology, additive manufacturing, and flexible electronics. Jeff received his PhD in Biophysics from Syracuse University, holds 4 patents, and has authored/co-authored more than 30 publications, including multiple book chapters. From 2008 -2018, he worked at the Lockheed Martin (LM) Advanced Technology Laboratories, before moving to LM Corporate in 2018 to managed engagements with the Manufacturing USA Innovation Institutes. Jeff has been honored with the LM Outstanding Leadership Award, the LM ATL Award of Distinction, and the Lockheed Martin NOVA Award.
Prior to Lockheed Martin, Jeff held research faculty positions at Syracuse University and the University of Connecticut. He has been PI on multiple grants from AFRL, ARO, NSF, the Army Institute for Collaborative Biotechnology, industry, and The NanoBio Manufacturing Consortium, where he served as Chair of the Governing Council through 2018. He currently serves on the BioMADE Education and Workforce Development Committee. In addition, Jeff serves on Lockheed Martin’s technical liaison team to NextFlex and was named a NextFlex Fellow in 2019.
Thomas Tubon is currently appointed as the Chief Workforce Development Officer for the recently-funded BioIndustrial Manufacturing and Design Ecosystem (BioMADE) Manufacturing Innovation Institute. BioMADE joins eight DoD-sponsored institutes as part of the Manufacturing USA network and is the16th institute invested in creating an end-to-end ecosystems for domestic manufacturing to secure America’s future through manufacturing innovation, education, and collaboration. Dr. Tubon leads the Education and Workforce Development initiatives of the BioMADE Institute, with a focus on building employment readiness for bioindustrial manufacturing and engineering biology.
Prior to his appointment with the BioMADE MII, Dr. Tubon served as a Professor in the Biotechnology Program at Madison Area Technical College for 13 years. During this time, he led several National Science Foundation Advanced Technological Education grant projects to establish and scale an emerging technology program in Stem Cells and Cell Manufacturing and oversee a Coordination Network project for Advanced Manufacturing of Cell and Tissue Products. While at Madison College, Dr. Tubon was responsible for the development of bioscience workforce and strategic implementation of programs for local, regional, and national-level adoption and scale-up. In this role, he has facilitated the creation of a broad network of industry, community, and academic stakeholders, that promote career pathways in Science, Technology, Engineering, and Mathematics (STEM). Dr. Tubon also serves as a subject matter expert with the NSF ATE Mentor Connect and Project Vision Programs.
Since 2019, Dr. Tubon has served as a CoPI on the NSF ATE InnovATEBIO Center for Biotechnology Education, and the NSF Advancing Research Impact in Society (ARIS) Center leadership team for workforce development and strategic partnerships.
Dr. Tubon holds a Ph.D. in Molecular Genetics from Stony Brook University and Cold Spring Harbor Laboratory and a BS in Molecular Biology from San Diego State University.
I have studied Technical Biology at the University of Stuttgart (Germany) and did a postdoc at Caltech (Arnold Lab) on Evolutionary Engineering of Enzymes. After my broad biotech education, I joined industry in 2000 to learn about development and implementation of Biotransformation as well we fermentation processes. After several development steps at my first industrial employer (former Degussa, now called Evonik Industries) I joined DSM in 2006. There I was responsible for a team to develop biocatalytic processes for pharma customers. In 2011 I accepted the job as R&D Director in our Innovation center where we developed biobased processes in the biofuels and bioplastic intermediates field. In 2015 I joined our Food Ingredients business as responsible Scientist for Biochemistry and Microbiology. In 2019 I joined our Animal and Human Nutrition business as Science Fellow for Biotechnology where we developed products and processes in the Nutritional Lipids, Carotenoids and Vitamins field. Since 2022 I am Senior Director Biotechnology and lead our Biotech R&D teams in Lexington (MA) and Columbia (Maryland).
I received my Masters of Science degree from George Mason University in 2007 and have been working with Government organizations over the past 20 years focused on helping these organizations understand advancements in biological sciences and how that can impact their mission space, specifically chemical and biological defense. I am employed with MITRE, a Federally Funded Research Development Center, where I continue to advise programs within the US Government on these areas.
Caroline Kennedy is a Lead Biotechnologist and Project Leader at The MITRE Corporation. She has worked there for the past eight years, during which she has supported numerous US Government organizations in biodefense and biosecurity matters, both domestic and international. For the past four years, much of her support has been in the field of One Health Security—a timely topic considering the zoonotic origins of the SARS-CoV-2 virus. Ms. Kennedy is also involved in MITRE’s internal R&D work program. She is a co-PI on a review of analytic methods used to detect and characterize veterinary antibiotics in surface water and is working as a Program Thrust Lead for Dr. Marc Salit’s Synthetic Biology R&D program. Ms. Kennedy enjoys working with students and has been an undergraduate team iGEM mentor as well as the MITRE POC for a new MIT/Lincoln Lab/MITRE co-developed Beaver Works Summer Institute course on Computational Biology and the Microbiome. Ms. Kennedy received her BA in Biology from the University of Virginia and is completing her MPH in Epidemiology at George Mason University in May 2022. She is also a mother of two young children and passionate about helping junior employees develop a healthy work/life balance, find their passion, and advocate for themselves as they progress in their careers.
My Bachelor’s degree is in Material Science & Engineering focusing on Polymers from University of Florida and received my PhD in Biomedical Engineering focusing on Bioimaging & Neuroscience from Columbia University. I am currently a Lead Biomedical Engineer at the MITRE Corporation and work on projects spaning from synthetic bioimaging, medical injury standards, biotechnology development, and synthetic biology. This includes regular interactions and partnerships with members of Government, industry, and academia.
My role at Corteva is as a molecular biologist working to enhance and develop new technologies for making recombination DNA vectors. But, I was an academic grad student and postdoc before teaching college biology for 9 years. Then I joined Corteva in 2016. (https://www.linkedin.com/in/slgasior/)
I am currently a third year PhD Candidate in the Biochemistry Molecular Biology and Biophysics (BMBB) program at the University of Minnesota Twin-Cities. Before I joined the BMBB program, I graduated from Southwestern University, in Georgetown Texas, with a Bachelor of Science in Chemistry in 2016. I then spent 3 years as a Lab Technician for Eco-Services in Houston Texas, which is a subsidiary of PQ Corporation specializing in sulfuric acid manufacturing.
Michaela is a postdoctoral researcher in Otto Cordero’s Lab at MIT working to expand the metabolic function of non-model ocean microbes. Prior to starting her postdoc, she completed her graduate work with Aditya Kunjapur at University of Delaware where she developed a new pathway for biosynthesis of non-standard amino acids and engineered a bacterial strain that was dependent on a non-standard amino acid for growth that can persist in soil microenvironments to build towards safely deployable synthetic microbes. As an EBRC board member, she serves as EMUMS chair to help provide academic mentorship to undergraduate and Master’s students interested in engineering biology.
Sanjeeva is a PhD student in Mansell lab at Iowa state university. His research work focuses on developing novel prebiotic-probiotic pairs for gut microbiome engineer. Prior to this, he completed his masters from IIT Guwahati, where he focused on constructing metabolic pathway to convert dairy waste to D-Lactic acid. Currently, he serves as a member of the EBRC SPA Board and works as the liaison to the Policy and International Engagement group. In addition, he also worked as a downstream process engineer for monoclonal antibody purification at Dr. Reddy Laboratories in India. Outside research, he enjoys watching cricket, playing badminton, running etc.
Edward is a postdoctoral fellow in the Ben Shen lab at UF Scripps. His research focuses on developing and utilizing synthetic biology approaches for natural product discovery and biosynthetic engineering, with an emphasis on biosynthetic gene cluster regulation. Prior to his postdoctoral position, he obtained his Ph.D. in the Gavin Williams lab at North Carolina State University where he engineered polyketide synthases and constructed transcription factor-based biosensors.
Dr. Keith R. Yamamoto is vice chancellor for science policy and strategy, director of precision medicine, and professor of cellular and molecular pharmacology at UCSF. After earning his PhD from Princeton University, Yamamoto joined the UCSF faculty in 1976. His research has focused on signaling and transcriptional regulation by nuclear receptors; he uses mechanistic and systems approaches to pursue these problems in pure molecules, cells and whole organisms. He has led or served on numerous national committees focused on public and scientific policy, public understanding and support of biological research, science education, and diversity, equity, inclusion and anti-racism; he currently chairs the Coalition for the Life Sciences, co-chairs the NASEM Roundtable on Aligning Incentives for Open Science, and sits on the Board of Directors of the Public Library of Science, the Board of Directors of Rapid Science, the Governing Board of the California Institute for Regenerative Medicine, the Board of Counselors for the Radiation Effects Research Foundation, and the Advisory Board for Lawrence Berkeley National Laboratory. He has chaired or served on many committees that oversee training and the biomedical workforce, research funding, and the process of peer review and the policies that govern it at NIH. He was elected to the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Academy of Microbiology, and is a fellow of the American Association for the Advancement of Science.
